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Abstract: Patient-specific three-dimensional (3D) printed models have been increasingly used in 
cardiology and cardiac surgery, in particular, showing great value in the domain of congenital heart 
disease (CHD). CHD is characterized by complex cardiac anomalies with disease variations between 
individuals; thus, it is difficult to obtain comprehensive spatial conceptualization of the cardiac 
structures based on the current imaging visualizations. 3D printed models derived from patient’s 
cardiac imaging data overcome this limitation by creating personalized 3D heart models, which not 
only improve spatial visualization, but also assist preoperative planning and simulation of cardiac 
procedures, serve as a useful tool in medical education and training, and improve doctor–patient 
communication. This review article provides an overall view of the clinical applications and 
usefulness of 3D printed models in CHD. Current limitations and future research directions of 3D 
printed heart models are highlighted. 
Keywords: three-dimensional printing; congenital heart disease; medical education; heart models; 
pre-operative planning; simulation 
 
1. Introduction 
Computed tomography (CT), magnetic resonance imaging (MRI), and echocardiography 
represent commonly used imaging modalities in the diagnostic assessment of congenital heart 
disease (CHD). These imaging techniques allow for generation of two-dimensional (2D) and three-
dimensional (3D) visualizations, which play an important role in understanding the complexity of 
CHD and assisting pre-procedural planning of cardiac procedures. Despite useful information 
provided by these imaging modalities, the images are still limited to be viewed on 2D screens which 
is very different from the physical models that offer realistic visualization of 3D spatial relationship 
between normal and anomalous anatomy. 3D printing overcomes this limitation by creating patient-
specific or personalized medical models [1–3]. The tactile experience offered by 3D printed models is 
another advantage over traditional image visualizations as the physical models enable 
comprehensive evaluation of anatomical and pathological structures which cannot be obtained by 
other methods [4]. 
3D printing has been increasingly utilized in the medical field with studies confirming its clinical 
value and usefulness in many areas, ranging from medical education to pre-surgical planning and 
simulation of complex surgeries, and to patient–doctor communication [5–10]. In particular, 
personalized 3D printed models have been shown to offer valuable information for treating patients 
with CHD due to complexity and anatomic variation associated with this disease. Most of the current 
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reports on 3D printing in CHD are dominated by isolated case reports or case series, with only a few 
single or multi-center studies and randomized controlled trials (RCT) available in the literature. This 
review aims to provide an in-depth overview of the current applications of 3D printed models in 
CHD, with limitations and future directions briefly highlighted. 
2. Image Post-Processing and Segmentation Process for Three-Dimensional (3D) Printing in 
Congenital Heart Disease (CHD) 
The first step to generate a 3D printed heart model is to undergo a series of image post-
processing and segmentation of volumetric data, which are commonly acquired with cardiac CT or 
MRI imaging. While high-resolution original datasets are important for accurately isolating the 
desired anatomy of interest and pathology from surrounding structures, segmentation of cardiac 
structures remains challenging due to complexity of cardiac features, especially in the CHD cases. 
Different software is used for segmentation, with Mimics (Materialise HQ, Leuven, Belgium) being 
the most commonly used commercial software and 3D Slicer (Brigham and Women’s Hospital, 
Boston, Mass) as the most common open-source tool. Several review articles have provided excellent 
description of details about the steps required from data acquisition to image post-processing and 
segmentation [11–14]. Figure 1 shows the steps to create 3D printed models from data acquisition to 
image post-processing and segmentation. 
 
Figure 1. Steps involved in fabrication of 3D printed heart models. CTA—computed tomography 
angiography; CMR—cardiac magnetic resonance; 3D—three-dimensional. 
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3. Accuracy of 3D Printed Heart Models 
The most important part of creating 3D printed models is to ensure that 3D models accurately 
delineate anatomical structures and pathologies since the model accuracy is essential for treatment 
planning [15]. Current research evidence indicates that 3D printed heart models are generally 
accurate [16], and this has been validated by other studies, either based on case reports/series or 
single- or multi-center studies [17–23]. In most of the studies, model accuracy is determined by the 
degree of agreement between the measured dimensions of the 3D printed model and the dimensions 
of original source images, usually using cardiac CT, MRI, and sometimes using rotational 
angiography or echocardiography [16–18,22], or intraoperative findings [19]. Currently, there is no 
standardized method to measure the dimensions of the 3D printed heart models. Most of the studies 
carried out measurement using calipers on the physical 3D printed models [17,20,21]. Only a few 
studies conducted measurement on the standard tessellation language (STL) file [18] and conducted 
CT scan on the 3D printed model for measurement [16]. The authors claimed it is easier to replicate 
the exact plane for measurement comparison, hence improving the accuracy of the results [16,18]. 
Despite limited studies available in the literature regarding quantitative assessment of 3D 
printed heart models, the accuracy of 3D printed heart models is within 1 mm in terms of dimensional 
differences when compared to the original images. Lau et al. compared model accuracy between 
contrast-enhanced CT images of the 3D printed heart model (Figures 2 and 3) and original cardiac 
CT images in 10 anatomical locations including ventricular septal defect (VSD) [16]. High accuracy 
was achieved between these measurements by only 0.23 mm difference in average. Ma et al., in their 
study comprising 35 patients of Tetralogy of Fallot (ToF), compared measurements of VSD sizes 
between 3D printed models and intraoperative findings with no significant differences found (mean 
value ± standard deviation: 14.98 ± 1.91 vs. 15.11 ± 2.06 mm, p > 0.05) [19]. This is further confirmed 
by a multi-center study showing the model accuracy. Valverde et al. recruited 40 patients diagnosed 
with complex CHD from 10 international centers in their prospective study [21]. 3D printed models 
were created from CT or MRI images, and they were found to be highly accurate with mean 
differences of 0.27 ± 0.73 mm between measurements performed on the 3D printed models and 
CT/MRI images. 
Currently, there is a lack of measurement comparison between 3D printed heart models and STL 
file, hence, it is unknown whether there is any dimensional error introduced during 3D printing 
process. This needs to be addressed by future studies. 
 
Figure 2. Comparison of virtual 3D reconstruction model (left) and 3D printed heart model (right). 
Reprinted with permission under the open access from Lau et al. [16]. 
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Figure 3. Scatterplot showing measurements of 3D printed model in comparison with those from 
cardiac computed tomography (CT) images at 10 anatomical locations. CCTA—cardiac computed 
tomography angiography. Reprinted with permission under the open access from Lau et al. [16]. 
4. 3D Printed Models in Medical Education and Training 
3D printed heart models have been shown to serve as a novel teaching tool in medical education 
and training and this is confirmed by RCT available in the literature [22–25]. Three of them reported 
the usefulness of 3D printed models of different types of CHD in medical education [22–24]. Table 1 
shows details of these three studies and other single- and multi-center reports. 
Studies by Loke et al. and White et al. investigated how 3D printed models improved pediatric 
residents’ knowledge and understanding of CHD, while the study by Su et al. focused on how 3D 
printed models improved medical students’ knowledge in CHD. In these studies, 3D printed models 
of VSD and ToF representing simple and complex CHD were created and used for teaching in the 
test groups (Figure 4), while the control groups were only given the usual lectures with 2D images. 
Overall results showed significant improvements of residents and medical students’ learning and 
confidence in managing CHD, especially in dealing with complex CHD situations such as ToF as 
confirmed by White et al. [24]. Furthermore, 3D printed models significantly improved residents’ 
satisfaction and self-efficiency scores when compared to learning from 2D images [22] (Figure 5). 
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Figure 4. 3D printed heart models showing normal anatomy and pathology. (a) Normal heart model 
created from cardiac CT and is partitioned into three pieces allowing visualization of interventricular 
septum. (b) Repaired Tetralogy of Fallot (ToF) from an adult patient. The model was created from 
cardiac magnetic resonance imaging (MRI) and separated into two pieces allowing for clear 
visualization of overriding aorta and pulmonary infundibular stenosis. (c) Unrepaired ToF heart 
model from an infant. The model was created from 3D echocardiographic images and partitioned into 
two pieces showing the ventricular septal defect (VSD). (d) Unrepaired ToF heart model from an 
infant with superior and inferior portions showing VSD and the aortic overriding in relation to the 
VSD. Reprinted with permission under the open access from Loke et al. [22]. Ao—Aorta; MPA—Main 
Pulmonary Artery; LV—Left Ventricle; RV—Right Ventricle; RVOT—Right Ventricular Outflow 
Tract; VSD—Ventricular Septal Defect; ToF—Tetralogy of Fallot. 
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Table 1. Study characteristics of randomized controlled trials and multi- and single-center studies. 
Authors Study design Sample size and participants Types of CHD Key findings 
Loke et al. 2017 
[22] 
RCT: study group was presented with 3D 
printed models, while control group with 
2D images 
35 pediatric residents: 
18 in study group and 17 in 
control group 
Tetralogy of Fallot (ToF) 
3D printed models resulted in significantly higher 
satisfaction scores than 2D images (p = 0.03). 3D printed 
models improved residents’ self-efficacy scores in 
managing ToF, although this did not reach significant 
difference when compared to 2D images (p = 0.39). 
Su et al. 2018 
[23] 
RCT: study group participated in teaching 
seminar including 3D printed models, 
while control group only attended teaching 
seminar without having 3D models 
63 medical students:  
32 in study group and 31 in 
control group 
Ventricular septal defect 
(VSD) 
Significant improvement in VSD learning and structure 
conceptualization in the study group compared to the 
control group (p < 0.05).  
White et al. 
2018 [24] 
RCT: study group was given 3D printed 
models in addition to lectures, while 
control group received only the lectures  
60 pediatric residents: 
31 in study group and 29 in 
control group 
VSD and ToF 
3D printed models of CHD improved residents’ 
knowledge and confidence in managing complex CHD 
such as ToF but did not seem to improve simple CHD 
such as VSD. 
Olivieri et al. 
2016 [26] 
Single-center report of 3D printed models 
for training and simulation  
10 3D printed models, 70 
clinicians participated in the 
training sessions 
Cardiac and vascular 
anomalies 
3D printed models can be used as a simulation training 
tool for multidisciplinary intensive care providers by 
enhancing their anatomic knowledge and clinical 
management of CHD patients. 
Hoashi et al. 
2018 [27] 
Single-center experience 20 cases 
DORV and other cardiac 
anomalies 
3D printed heart models improved understanding of the 
relationship between intraventricular communications 
and great vessels. Further, 3D printed models allowed 
simulation of cardiac surgeries by creating intracardiac 
pathways, thus providing benefits to inexperienced 
cardiac surgeons. 
Valverde et al. 
2017 [21] 
Multi-center study consisting of 10 
international centers 
40 patients with complex 
CHD 
DORV (50%) and other 
cardiac anomalies 
3D models were accurate in replicating anatomy. 3D 
models refined the surgical approach in nearly 50% cases. 
3D models resulted in significant change in the surgical 
plan in 24% of cases. 
Zhao et al. 2018 
[28] 
Single-center experience  
25 patients with 8 in 3D 
printing group and 17 in 
control group 
DORV 
3D printed models showed high accuracy in 
measurements of aortic diameters and the size of VSD 
when compared to original CT data. 3D printed models 
significantly reduced ICU time and mechanical 
ventilation time (p < 0.05). 
Ryan et al. 2018 
[29] 
Single-center experience 
Of 928 cardiothoracic 
surgeries, 164 3D models were 
printed for various purposes 
DORV, ToF and other 
cardiac anomalies 
3D printed models reduced mean time in the operating 
room and 30-day readmission and mortality rates when 
compared to the standard of care. 
CHD—congenital heart disease, DORV—double outlet right ventricle, ICU—intensive care unit, RCT—randomized controlled trial. 
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Figure 5. Impact of 3D printed heart models on medical education. Improvement was found in 
residents’ knowledge on congenital heart disease with use of 3D printed models when compared to 
2D images. A statistically significant difference was noticed in satisfaction ratings in the group having 
3D printed heart models when compared to the control group (p = 0.03). While residents in the 3D 
printed model group had higher self-efficacy scores, this did not reach significant difference 
compared to the control group using 2D images/drawings (p = 0.39). Reprinted with permission under 
the open access from Loke et al. [22]. 
Results from cross-sectional studies are consistent with these findings from RCT [5,6,30–32]. To 
date, there is sufficient evidence to prove that 3D printed models of CHD play a valuable role in 
education and training of medical students, pediatric residents, and healthcare professionals in 
improving their understanding of complex cardiac pathology and increasing their confidence in 
managing CHD patients. 
5. 3D Printed Models in Pre-Surgical Planning and Simulation 
Due to complexity of the cardiac conditions with wide variations between individuals with 
CHD, 3D printed models demonstrate great advantages over traditional image visualizations in pre-
surgical planning and simulation of cardiac surgeries. A recent systematic review has summarized 
findings from a number of case reports and series with regard to the use of 3D printed models in 
facilitating preoperative planning and surgical decision-making in CHD cases [33]. Table 1 shows 
some results from single- and multi-center studies which involved more than 20 cases or participants 
about the value of 3D printed heart models in this aspect [20,26–29]. These studies reported the 
usefulness of 3D printed heart models from different perspectives. Among all types of CHD, double 
outlet right ventricle (DORV) and ToF represent the most common types of CHD for fabrication of 
3D printed models. This is reported in four out of the five studies mentioned above [21,27–29]. 
Olivieri et al. created 3D printed models from 10 patients who underwent congenital cardiac 
surgery due to various cardiac and vascular anomalies [26]. They presented the 3D models to 70 
clinicians including 22 physicians, 38 critical care nurses, and 10 ancillary providers. At completion 
of the cardiac surgeries, all participants underwent a training session of simulating intra- and post-
operative care using 3D printed heart models. The use of 3D printed models was found to be more 
effective than standard verbal hand off with average score of 8.4 out of 10. In total, 90% of participants 
scored it very highly with regard to the efficacy of 3D printed models in improving cardiac anatomy 
understanding, surgical understanding, and ability to manage CHD clinically. 
Two other studies reported utilizing 3D printed heart models in the diagnostic management of 
patients with CHD [21,27]. Hoashi et al. created 20 3D printed heart models for the purpose of 
preoperative simulations of cardiac surgeries [27]. Despite realistic and expensive models being 
produced (each model costs between $2000 and $3000), this study mainly focused on findings related 
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to patient’s cardiac surgery outcomes, while the value of 3D printed models was briefly mentioned 
in some sample cases. Specifically, authors concluded that 3D printed heart models did not reduce 
cardiopulmonary bypass time. In contrast, Valverde et al. conducted a multi-center study and 
performed both quantitative and qualitative assessments of the role of 3D printed models in clinical 
decision-making in patients with complex CHD [21]. Forty patients recruited from 10 international 
centers were included in this prospective study with 3D models fabricated using CT or MRI images. 
3D printed models were assessed as to whether they changed the surgical decision (from conservative 
management to surgical intervention) and whether the surgical plan was modified. In more than half 
of the cases (52.5%), 3D printed models did not result in any change to the surgical decision. 
However, 3D printed models showed significant clinical impact on redefining the surgical approach 
in 47.5% cases. In 25% of cases, after inspection of 3D printed models, the surgical plan was modified 
with conservative management changed to surgery. As the only multi-center study available in the 
literature, this study shows the impact of 3D printed models on deciding the best surgical approach. 
However, more similar studies are desirable to validate this. 
The other two studies are based on single-center experience reporting the clinical impact of 3D 
printed models in CHD treatment outcomes [28,29]. Zhao et al. divided 25 patients with complex 
DORV into two groups, 8 in the 3D printing group and 17 in the control group, with all patients 
undergoing cardiac surgery [28]. The intensive care unit stay time and mechanical ventilation time 
in the 3D printing group was significantly shorter than in the control group (p < 0.05). Although the 
operative duration, cardiopulmonary bypass time, and aortic cross-clamping time in the 3D printing 
group was shorter than the control group, this did not reach statistical significance (p > 0.05). Similar 
findings are reported by Ryan and colleagues [29]. The authors presented their single-site three-year 
experience of using 3D printed models for managing CHD cases. Of 164 models fabricated for 
different purposes, 79 models covering a range of CHD complexities were selected for surgical 
planning. When compared to the standard care (without anatomical models) group, the 3D printed 
heart model group was found to have shorter mean duration in the operative room and lower 30-day 
readmission and mortality rates. However, it is worthwhile to note that it did not reach statistical 
significance, and it is likely due to limited study sizes for each CHD types. These reductions in 
durations could contribute to lower morbidity and mortality associated with management of CHD, 
although this needs to be validated by further studies. One example would be by investigating the 
impact of 3D printed models on 30-day post-operative outcome. 
6. 3D Printed Models in Doctor–Patient Communication 
Physician–patient relationship and working alliance plays a crucial role in improving patient 
adherence, level of satisfaction, and treatment outcomes [34]. Due to complexity and variations of 
cardiac anatomy in CHD, it is especially challenging in achieving good physician–patient 
communication (physicians specifically refer to cardiologists and cardiac surgeons in the situation of 
managing patients with CHD) [35]. Traditional approaches of using diagrams or image visualizations 
for explanation of complicated cardiac pathologies do not allow doctors to effectively communicate 
to patients or parents because of difficulty in interpreting 3D conceptualization of spatial relationship 
between cardiac structures. 3D printed models are able to eliminate this limitation as observers have 
no restriction in appreciating the spatial relationship between cardiac structures in all dimensions, 
thus improving doctor–patient communication. 
A study by Biglino et al. first attempted to quantify the benefit of 3D printed models in doctor–
patient communication [36]. Ninety-two parents of patients with CHD were randomly allocated to 
two groups with 45 assigned to the model group using 3D printed heart models during their visit, 
and 52 to the control group with no models during consultation. Parents were asked to complete two 
questionnaires: A first brief questionnaire before their child’s consultation and a second brief 
questionnaire after the consultation with regard to understanding of their child’s heart condition, 
identification of cardiac defects, and clarity of planned intervention or procedure. Both cardiologists 
and parents rated the 3D printed models as very useful. Despite the improvement in doctor–parent 
communication, 3D printed models did not lead to improving parents’ knowledge and 
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understanding of their child’s heart condition. Furthermore, consultations using the 3D printed 
models were found to be longer than those without the models (21 ± 10 vs. 16 ± 7 min, p = 0.02), 
although this did not show significant impact on overall duration of the visits. 
The same group conducted another study determining the impact of using 3D printed heart 
models on facilitating consultations between doctor and young people with CHD [37]. Twenty 
adolescent patients with CHD (age range 15–18 years) were included in this study with use of the 
same approach as stated in the previous study involving completion of two questionnaires, pre and 
post-consultations with their doctors. Positive responses were found in the study with use of 3D 
printed models with significant improvements in their knowledge of CHD (p < 0.05), confidence in 
explaining conditions to others (p < 0.001), and overall satisfaction (p < 0.05) (Figure 6). The majority 
of participants indicated that the 3D printed models improved their clinical visits, however, 30% of 
them expressed their concern of feeling more anxious about their heart condition with use of the 3D 
models (Figure 7). 
More research is needed to investigate the clinical translation of 3D printed heart models for 
doctor–patient/parent communication with involvement of different stakeholders including patients, 
parents, families, clinicians, and other healthcare professionals such as nurses and ancillary providers 
[28]. Further studies are also required to address the limitations of lack of evidence of clinical follow-
up with regard to the impact of 3D printed models on patient’s lifestyle and eventually patient 
outcomes. 
 
Figure 6. Statistically significant differences were noted in confidence (A), knowledge (B), and 
satisfaction (C) amongst participants comparing responses before (“Pre”) and after (“Post”) their 
medical consultation. (A) 1 refers to not at all confident and 5 very confident. (B) Each point represents 
a point in knowledge, as marked based on the correct name of primary diagnosis, correctly identified 
keywords, and correct use of diagrams. (C) 1 indicates very dissatisfied and 5 very satisfied. The red 
lines indicate average score. Reprinted with permission under the open access from Biglino et al. [36]. 
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Figure 7. Participants’ response to different statements on the usefulness of 3D printed models. 
Reprinted with permission under the open access from Biglino et al. [36]. 
7. Summary and Future Research Directions 
Personalized 3D printed models of CHD are changing the current practice in the diagnostic 
management of patients with CHD. 3D printed models have demonstrated advantages over 
traditional image visualizations in the assessment of complex cardiac structures as observers are able 
to appreciate various CHD conditions with more confidence. Three main applications of 3D printed 
heart models have been discussed in this review, including medical education and training, pre-
surgical planning and simulation, and doctor–patient communication. Despite attractiveness of 3D 
printed realistic models and promising results associated with their applications, more scientific 
evidence with high statistical power is needed before 3D printing is widely used in clinical practice. 
In addition to the lack of large-scaled studies (prospective and multi-center studies), some limitations 
should be addressed with future technical developments so that 3D printing will be more practicable 
in medical applications. 
One of the main limitations in generating 3D printed heart models lies in image post-processing 
and segmentation of cardiac imaging data, which is exceptionally time-consuming and requires 
expertise in image analysis. The duration needed to complete the segmentation and image post-
processing is highly dependent on segmentation software tools (whether it is powerful enough for 
automatic segmentation), and researcher’s familiarity with the software, as highlighted by two 
systematic reviews and other review articles (Table 2) [29,35,38–40]. This operator-dependent process 
is inevitably associated with interobserver and intraobserver variability. This limitation could be 
resolved with the use of artificial intelligence or machine learning algorithms which are increasingly 
used in the domain of cardiovascular disease by providing automated image segmentation of 
coronary plaque lesions or coronary lumen [41–44], thus improving the workflow efficiency from 
image acquisition to 3D printing. 
High 3D-printing costs represent another obstacle, however this is being resolved with the use 
of low-cost 3D printing materials, provided that the accuracy of the 3D printed models is not affected. 
A recent study has demonstrated the feasibility of creating accurate 3D printed models using low-
cost as opposed to high-cost material ($50 vs. $300) for delineation of cardiac anatomy and defects 
(Figures 8 and 9) [45]. With further cost reductions in 3D printers and printing materials in the near 
future, personalized 3D printed heart models will become more affordable to patients with CHD. 
Table 3 shows different types of 3D printers and printing materials that are available in the 3D 
printing of cardiac models and strengths and weaknesses of these models corresponding to each type 
of 3D printers [36,46–49]. 
Very few materials that are currently used for creating 3D printed heart models represent elastic 
properties similar to human tissue which allow for performance of realistic surgical simulation such 
as cutting and suturing of cardiac structures. Despite softness of the Tango Plus material as shown in 
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Figure 9, the mechanical properties of these materials are still different from biologic heart tissues. 
Furthermore, current 3D printers generate a static heart model instead of a dynamic organ, therefore, 
allowing for assessment of morphological cardiac features rather than hemodynamics of the 
cardiovascular system. Future developments in printing technologies should aim to produce 3D 
printed dynamic heart models which enable detection of both anatomic and physiological changes 
during the cardiac cycle [11,39,50]. 3D bioprinting represents another major advancement with the 
capability of printing biomaterials, 3D printed tissue scaffolds, and 3D printed functional vascular 
networks [51–53]. Bioprinting of patient-specific heart tissues will broaden applications of 3D 
printing in CHD, although many challenges need to be overcome before it can be translated to clinical 
applications [54,55]. 
Currently, no guidelines or recommendations are available regarding the standardized use of 
3D printed models in CHD patients. Use of 3D printed models is limited to complex CHD such as 
DORV (Figure 10) and ToF as evidenced by anecdotal reports and case series [16,21–23,31–33,56,57]. 
Other clinical benefits of using 3D printed heart models such as its impact on procedural safety and 
long-term outcomes are still yet to be investigated. Future research should focus on these areas as 
they will contribute to the development of clinical recommendations of using 3D printed models 
routinely in medical practice, therefore having great impact on the treatment of congenital heart 
disease. Figure 11 presents a summary of the current applications and future directions of 3D printing 
in CHD. 
Table 2. Summary of systematic reviews of 3D printed models in congenital heart disease. 
Authors 
Number of 
studies 
analyzed 
Review purpose Key findings 
Batteux et 
al. 2019 [38] 
NR 
Accuracy and reliability of 
3D printed models in surgical 
planning in complex CHD 
3D printed models improve understanding of complex 
cardiac anatomy and disease and can be used to guide 
surgical planning. 
Lau and 
Sun 2018 
[29] 
28 
Clinical value of 3D printed 
models in CHD 
3D printed models accurately replicate cardiac 
anatomy and pathology and are shown to be valuable 
in preoperative planning and simulation of cardiac 
procedures. 
NR—Not reported. 
   
(A) (B) (C) 
Figure 8. CT scan of 3D printed heart models created using different printing materials. (A) 3D 
volume rendering showing the 3D printed models without contrast medium (top: Tango Plus 
material, bottom: TPU material). (B,C) Coronal multiplanar reformatted contrast-enhanced CT 
images showing 3D printed models with Tango Plus (left) and TPU (right) materials. Air bubbles are 
noticed in the model with TPU material. TPU—thermoplastic polyurethane. Reprinted with 
permission under the open access from Lau et al [45]. 
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Figure 9. Comparison of low-cost (left image) with high-cost (right image) 3D printed heart model 
with similar accuracy in delineating cardiac anatomy and ventricular septal defect. 
 
Figure 10. Example of double outlet right ventricle with aorta and pulmonary artery arising from the 
right ventricle and perimembranous ventricular septal defect from computed tomography images 
(A,B,C). Anterior view of the 3D printed heart model, aorta, and pulmonary artery are side-by-side 
with both arising from the right ventricle (D). Perimembranous VSD remoted from the arteries. 
Position of potential intracardiac tunnel from the left ventricle to the aorta is shown as the solid lines 
(E). AO—ascending aorta; LA—left atrium; LV—left ventricle; PA—pulmonary artery; RA—right 
atrium; RV—right ventricle; VSD—ventricular septal defect. Reprinted with permission from Zhao et 
al [32]. 
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Table 3. Summary of different types of 3D printing technologies and corresponding 3D printed heart models. Adapted from References [36,46–49]. 1 
3D Printing 
Technologies 
Printing 
Materials Advantages Disadvantages 
3D Printed Heart Models 
Strengths Weaknesses 
Stereolithography 
(SLA) 
Photopolymers Large part size High cost, moderate strength  
High detail and 
accuracy, smooth 
surfaces 
Low tensile strength 
Polyjet (PJ) Photopolymers 
Variety of materials 
including multi-colored 
materials 
Slow speed, high cost 
High accuracy with 
flexibility, durability, 
and translucency 
Low tensile strength 
Selective Laser 
Sintering (SLS) 
Powder 
materials 
Large part size, variety of 
materials and good 
strength 
High cost, low resolution Moderate accuracy Inferior anatomical 
details 
Binder Jetting (BJ) Powder materials 
Very low cost, variety of 
materials, relatively fast, 
does not use heat 
Slow speed, fragile parts 
with limited mechanical 
properties 
NR Low accuracy 
Fused Deposition 
Modeling (FDM) 
Thermoplastic 
materials 
Low cost, variety of 
materials, good strength 
Slow speed and a scaffold is 
needed to support the object 
during printing 
Moderate accuracy, 
more suitable for 
medical devices 
Limited values in 
surgical and 
anatomical models 
  2 
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Figure 11. Summary of current applications and future research directions of 3D printing in 
congenital heart disease. 3D—three-dimensional; CHD—congenital heart disease; AI—artificial 
intelligence. 
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